Display options
Cite
Thomas KD, Adhikari AV, Chowdhury IH, et al. Design, synthesis and docking studies of quinoline-oxazolidinone hybrid molecules and their antitubercular properties. Eur J Med Chem. 2011;46(10):4834-45doi: 10.1016/j.ejmech.2011.07.049.
Thomas, K. D., Adhikari, A. V., Chowdhury, I. H., Sandeep, T., Mahmood, R., Bhattacharya, B., & Sumesh, E. (2011). Design, synthesis and docking studies of quinoline-oxazolidinone hybrid molecules and their antitubercular properties. European journal of medicinal chemistry, 46(10), 4834-45. https://doi.org/10.1016/j.ejmech.2011.07.049
Thomas, K D, et al. "Design, synthesis and docking studies of quinoline-oxazolidinone hybrid molecules and their antitubercular properties." European journal of medicinal chemistry vol. 46,10 (2011): 4834-45. doi: https://doi.org/10.1016/j.ejmech.2011.07.049
Thomas KD, Adhikari AV, Chowdhury IH, Sandeep T, Mahmood R, Bhattacharya B, Sumesh E. Design, synthesis and docking studies of quinoline-oxazolidinone hybrid molecules and their antitubercular properties. Eur J Med Chem. 2011 Oct;46(10):4834-45. doi: 10.1016/j.ejmech.2011.07.049. Epub 2011 Aug 04. PMID: 21880400.
Copy Download .nbib Format: NLM
Share it on

Eur J Med Chem. 2011 Oct;46(10):4834-45. doi: 10.1016/j.ejmech.2011.07.049. Epub 2011 Aug 04.

Design, synthesis and docking studies of quinoline-oxazolidinone hybrid molecules and their antitubercular properties.

European journal of medicinal chemistry

K D Thomas, Airody Vasudeva Adhikari, Imran H Chowdhury, T Sandeep, R Mahmood, B Bhattacharya, E Sumesh

Affiliations

  1. Anthem Biosciences Pvt. Ltd, No. 49, Bommasandra Industrial Area, Bommasandra, Bangalore 560099, Karnataka, India.

PMID: 21880400 DOI: 10.1016/j.ejmech.2011.07.049

Abstract

New series of quinoline-oxazolidinone hybrid molecules were synthesized based on the preliminary docking studies. All the newly synthesized compounds were characterized by spectral analyses. The newly synthesized compounds were screened for their antimycobacterial properties based on the promising preliminary antibacterial screening results. Amongst tested compounds, compounds 8a, 8j and 13a were active at 0.65 μg/mL against Mycobacterium tuberculosis H(37)Rv strain. The mode of action of these active compounds was carried out by docking of receptor enoyl-ACP reductase with newly synthesized candidate ligands 8a, 8j and 13a. These compounds exhibited well established bonds with one or more amino acids in the receptor active pocket. From the docking studies, compound 8j was considered to be the best inhibitor.

Copyright © 2011 Elsevier Masson SAS. All rights reserved.

Substances

MeSH terms

Publication Types